Specialty Health and Rehabilitation Center

In the surveyor’s words

From the most serious findings on record at Specialty Health and Rehabilitation Center, in the surveyor’s own words.

• No harm, potential for more than minimal, isolatedF880Jun 22, 2026

  Based on observations, interviews and record review, the facility failed to follow acceptable nationally accepted infection prevention and control standards including proper use of Personal Protective Equipment (PPE) to prevent the spread of infections by staff involved in direct resident care in 1 out 1 resident observed. (Resident #2)The findings include:On 06/22/2026 at approximately 8:53 AM, an observation of Resident #2 was performed. An Enhanced Barrier Precaution (EBP) sign was posted on the outside of his door. (Photographic evidence obtained). The resident's urinary catheter tubing was observed disconnected from the catheter port. A staff member notified Staff B, Licensed Practical Nurse (LPN), who arrived with the catheter drainage bag replacement. […]

• No harm, potential for more than minimal, isolatedF656Oct 2, 2025

  Based on observations, staff interviews, and record reviews, the facility failed to develop and implement a comprehensive-person centered care plan for the safety and use of oxygen therapy for 1 of 1 residents sampled for oxygen use. (Resident #39)The findings include:Resident #39 was observed wearing oxygen via nasal cannula with the flow of 1 liter per minute (lpm) on the following dates and times: 9/29/25 at 12:20 PM, 9/30/25 at 9:40 AM, 9/30/25 at 12:15 AM, 10/01/25 at 9:30 AM, and 10/01/25 at 2:00 PM.An interview was conducted with Nurse C, a Licensed Practical Nurse (LPN), on 9/30/25 at approximately 9:45 on 9/30/25. […]

• No harm, potential for more than minimal, isolatedF757Oct 2, 2025

  Based on observations, interviews, and record review, the facility failed to provide adequate monitoring of labs for 1 of 5 residents sampled for unnecessary drugs. (Resident #3)The findings include:Resident #3's medical record revealed an active diagnosis of cirrhosis of the liver and ascites. The medical record revealed the active medications for diagnosis of cirrhosis of the liver and ascites are the following: 1.Xifaxan Tablet 550 Milligram- Give one tablet by mouth two times a day related to Unspecified Cirrhosis of the liver. 2. Ursodiol Capsule 300 Milligram- Give one capsule by mouth one time a day for Biliary Cirrhosis. 3. […]

• No harm, potential for more than minimal, isolatedF919Oct 2, 2025

  Based on observations and staff interviews, the facility failed to ensure that the call system was adequate to allow residents to call for staff assistance through a communication system in 1 of 16 sampled resident rooms (room [ROOM NUMBER]-1) and 2 of 16 sampled resident restrooms (room [ROOM NUMBER] and 347). The findings include: An observation and test of the resident room call system in room [ROOM NUMBER]-1 was conducted on 9/29/25 at 2:48 PM with Employee G (Certified Nursing Assistant). The call system for 302-1 did not appear functional. Employee G acknowledged it was not functional. An observation of the restroom call system cord for room [ROOM NUMBER] was conducted on 9/29/25 at 3:08 PM. The call system cord was observed to be too short to reach the toilet. […]

• No harm, potential for more than minimal, isolatedF842Jul 11, 2024

  Based on record review, interviews and facility policy review, the facility failed to complete medication administration records (MARs) for 1 of 3 residents sampled for intravenous therapy. (Resident #316) The findings include: A review of Resident #316's medical record was conducted. A physician's order was found for Merrem (meropenem) intravenous solution reconstituted 500 mg (an antibiotic) every 8 hours for prophylaxes with a start date of 2/6/24 and a discontinue date of 2/28/24. Another physician's order stated that Cubicin (daptomycin) solution reconstituted 500 mg (another antibiotic) use 500 mg intravenously every 24 hours for prophylaxis related to right knee revision was to be started on 1/29/24 and discontinued on 2/28/24. […]